Brown & Brown 2025-26: Accession Acquired, Revenue $5.9B (+23%), Margin 35.9%
FY25 revenue $5.96B (+23% on Accession + 43 acquisitions); op income $1.70B (+24%); NI $1.05B (+6%); EPS $3.16 (-9% on Accession dilution + share count). Q4 revenue $1.6B (+35.7% YoY). Adj EBITDAC margin 35.9% (+70bp YoY). Cash flow from operations $1.45B (+23.5%). 43 acquisitions FY25 (~$1.8B annualized revenue, including Accession $405M Q4 — largest acquisition in BRO history). Q4 retail organic +1.1%; full-year retail organic +2.8%. Q4 Specialty Distribution organic -7.8% (flood claims revenue + CAT property rate declines). FY26 framework: Accession EBITDA synergies $30-$40M; specialty distribution contingents down ~$15M; adj EBITDAC margin LT target raised to 32-37%; effective tax rate 24-25%.
Key takeaways
- 43 acquisitions FY25 (~$1.8B annualized revenue) — including Accession (largest acquisition in company history). This is the central FY25 story. Brown & Brown's M&A engine compounding faster than ever — full-year added $1.8B annual revenue from acquisitions vs $5.96B total revenue (~30% inorganic contribution). Accession alone contributed $405M Q4 (slightly below $430-$450M guide, ~200bp Q4 margin impact reflecting integration timing). The integration overhead is real but contained.
- Adj EBITDAC margin 35.9% (+70bp YoY) — long-term target raised to 32-37%. Despite Accession integration drag of ~200bp on Q4 margin, full-year FY25 margin still expanded. The structural margin trajectory is intact. Mgmt raised the LT margin target from prior 30-32% range to 32-37% — meaningful upward shift, reflecting confidence in scaled organization economics.
- Q4 retail organic +1.1% / full-year +2.8%; Specialty Distribution Q4 organic -7.8%. The retail segment (~70% of revenue) is the clean compounder — modest organic growth + disciplined execution. Specialty Distribution Q4 -7.8% organic reflects: flood claims processing revenue (one-time) + greater-than-expected CAT property rate declines (insurance market mix shift). Specialty Distribution full-year +2.8% organic — Q4 was the worst quarter on cycle dynamics.
- Cash flow from operations $1.45B (+23.5% YoY). Strong cash generation supports M&A engine. The capital allocation framework: organic growth → operating cash flow → M&A redeployment → continued compounding. Operating cash flow growth of +23.5% outpacing reported revenue +23% reflects margin expansion + working capital efficiency.
- Loss of 275 teammates with $23M revenue — talent risk noted. Mgmt explicit on Q4 call. Industry-wide talent wars in insurance brokerage. BRO has nonpiracy / nonsolicitation agreements + legal defenses but acknowledges future business impact uncertain.
Business
Brown & Brown, Inc. is one of the largest independent insurance + risk management brokers in the US, providing wholesale + retail commercial + personal insurance + specialty distribution + reinsurance services. Three reportable segments + active M&A pipeline:
- Retail (~70% of revenue). Commercial + personal lines property & casualty insurance broking + employee benefits + risk management. Q4 organic +1.1%; full-year +2.8%. The structural compounder + M&A integrator.
- Specialty Distribution (formerly Wholesale) (~25%). Wholesale insurance distribution + binding authority + program / MGA / MGU placements + reinsurance brokerage. Q4 organic -7.8% (flood claims processing revenue + CAT property rate declines); full-year +2.8% organic.
- Services / Other (~5%). Smaller segments including Bridge software, services revenue.
Strategic moves FY25:
- Accession acquisition closed (largest in BRO history; $405M Q4 revenue contribution)
- 43 total acquisitions completed FY25
- ~$1.8B annualized revenue added through M&A
- 6 acquisitions in Q4 alone ($29M annualized revenue)
- Long-term adjusted EBITDAC margin target raised to 32-37% (from prior 30-32%)
- Loss of 275 teammates / $23M revenue (talent war drag)
- Non-piracy / non-solicitation agreements + legal defenses
- Q4 Specialty Distribution flood claims processing revenue (one-time)
- CAT property rate declines greater than expected
- Cash flow from operations $1.45B (+23.5%)
- Adjusted EBITDAC margin 35.9% (+70bp)
- Buybacks $-100M FY25 (vs $-55M FY24, +82%)
- Dividend $-194M (+26% YoY) — meaningful raise
FY25 financial performance
| Metric (FY) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue ($B) | 3.56 | 4.20 | 4.71 | 5.96 |
| Revenue YoY | n/a | +18% | +12% | +27% |
| Op income ($B) | 0.96 | 1.16 | 1.37 | 1.70 |
| Op margin | 27.0% | 27.5% | 29.1% | 28.5% |
| Net income ($M) | 672 | 871 | 993 | 1,054 |
| Diluted EPS ($) | 2.37 | 3.05 | 3.46 | 3.16 |
| FCF ($B) | 0.83 | 0.94 | 1.09 | 1.38 |
| Capex ($M) | -52 | -69 | -82 | -68 |
| Total debt ($B) | 4.18 | 4.02 | 4.06 | 7.92 |
| Dividends ($M) | -120 | -135 | -154 | -194 |
| Buyback ($M) | -123 | -40 | -55 | -100 |
The earnings progression: revenue compounded at ~LSD-MSD organic + meaningful M&A acceleration — 4-yr CAGR ~14%. Op income +14%/year on average. EPS dropped from $3.46 FY24 → $3.16 FY25 reflecting Accession share issuance dilution + integration costs not yet annualized.
The standout metrics: cash flow from operations $1.45B (+23.5%) and adj EBITDAC margin 35.9% (+70bp). Total debt jumped to $7.92B (+95% YoY) — Accession funding via debt issuance. FY26-27 deleveraging will be a key capital allocation watch.
Capital allocation
- Capex $-68M FY25 (-17% YoY). Light-asset model.
- Dividends $-194M FY25 (+26% YoY). Meaningful dividend acceleration.
- Buybacks $-100M FY25 (+82% YoY).
- M&A 43 acquisitions; ~$1.8B annualized revenue added; Accession largest in history.
- Debt $7.92B (+95% YoY). Accession funding.
- FCF $1.38B (+27% YoY).
- Cash flow from operations $1.45B (+23.5% YoY).
The capital allocation algorithm is dominant in BRO's thesis: operating cash flow → M&A acquisitions (~30% of revenue inorganic) + dividends (raising) + selective buybacks. The 2026 question is leverage paydown post-Accession.
FY26 outlook (per Q4 2025 call, 2026-01-27)
| FY26 framework | Detail |
|---|---|
| Accession synergies | EBITDA $30M-$40M anticipated 2026 |
| Specialty Distribution contingents | -~$15M (one-time adjustments + storm activity) |
| Retail organic growth | Modest improvement |
| Specialty Distribution organic | Improved organic growth |
| Long-term adj EBITDAC margin | 32-37% (raised from 30-32%) |
| Effective tax rate | 24-25% |
| Accession seasonality | More weighted to Q3; Q1 margin impact continues |
The framework suggests: continued M&A integration + Accession synergies + organic stabilization + margin expansion toward 32-37% target. Implicit FY26 revenue growth midpoint mid-teens (organic + acquisitions). Adj EPS midpoint should grow with margin expansion + lapping Accession integration costs.
Key risks
Accession integration execution. $30M-$40M EBITDA synergies anticipated 2026 — depends on integration progress. Q1 margin impact continues; if integration extends, FY26 margin compresses further before recovery. The largest acquisition in BRO history carries proportionally larger risk.
Talent war / departing teammates. 275 teammates / $23M revenue lost FY25 — material absolute number. Insurance brokerage is people-intensive; talent retention + recruitment + non-solicitation litigation cost matter. Future business impact uncertain per mgmt.
Insurance pricing volatility. Q4 Specialty Distribution organic -7.8% reflects greater-than-expected CAT property rate declines + flood claims revenue normalization. Insurance market cycles affect organic growth + commission economics.
Specialty Distribution contingent commissions. FY26 -$15M expected from one-time adjustments + storm claim activity. Contingent commissions are inherently volatile; year-over-year comparisons cyclical.
Leverage post-Accession. Total debt $7.92B (+95% YoY) reflects Accession funding. FY26 deleveraging pace + interest expense + refinancing needs all matter. Higher rates compress; rate cuts support.
M&A integration capacity. 43 deals FY25 + Accession = significant integration load. Operational risk of M&A pace exceeding integration capability. BRO has historically managed well but the Accession scale tests capacity.
M&A pricing discipline. Insurance brokerage M&A multiples have inflated; BRO's 4-7x EBITDA target range under pressure. If pricing discipline slips, capital efficiency declines.
Casualty rate increases vs E&S property declines. Mixed insurance pricing creates winners + losers across segments. BRO's casualty exposure benefits while E&S property exposure compresses. Mix navigation matters.
Regulatory environment. State insurance commissioners + federal regulators affect agent / broker compensation models, contingent commissions, tied selling rules. Regulatory changes can compress margins.
Recession scenario. Insurance broking generally counter-cyclical (commercial premium tied to economic activity but with lag) but recession does compress small-business segment + new business activity.
Goodwill / intangibles. Heavy M&A creates large goodwill + intangible balance — impairment risk if business performance disappoints.
Successor / leadership transitions. Q4 call opened with condolences on passing of Chief Legal Officer. Leadership transitions create operational risk during integration phases.
Bottom line
Brown & Brown FY25 is the M&A acceleration year combined with Accession transformational deal: revenue +23%, op income +24%, cash flow from operations +23.5%, adj EBITDAC margin +70bp to 35.9%. 43 acquisitions completed FY25; Accession (largest in history) added $405M Q4 revenue. Long-term adj EBITDAC margin target raised to 32-37% — meaningful upward shift reflecting confidence in scaled organization economics.
The FY26 framework: Accession EBITDA synergies $30-$40M anticipated; Specialty Distribution contingents down ~$15M one-time; retail + specialty organic stabilization expected; effective tax rate 24-25%. The implicit FY26 setup: continued integration + margin expansion + lapping Accession Q1 drag + organic stabilization.
The risks are real — Accession integration execution (largest deal ever), talent war (275 teammates lost / $23M revenue), insurance pricing volatility, Specialty Distribution contingents, leverage post-Accession ($7.92B debt + 95% YoY), M&A integration capacity (43 deals + Accession), pricing discipline, mixed insurance rates, regulatory, recession scenario, goodwill / intangibles, leadership transitions.
But the structural thesis (largest independent insurance broker + 43 acquisition cadence + Accession scale + long-term margin target raised + cash flow strength + disciplined capital allocation) is intact and FY25 print confirms.
Quality insurance brokerage compounder mid-Accession integration. The M&A engine + organic stability + margin expansion + capital return creates a multi-year compounding setup. The integration of Accession + delivery of $30-$40M synergies + Specialty Distribution recovery are the key 2026 watchpoints. Investors get exposure to insurance brokerage industry consolidation + recurring commission economics + balance-of-payments-style M&A cash conversion.
Citations
- Brown & Brown, Inc. FY25 Form 10-K (filed February 2026, SEC EDGAR).
- BRO Q4 2025 earnings call, 2026-01-27 — FY revenue $5.96B (+23%); Q4 revenue $1.6B (+35.7%); adj EBITDAC margin 35.9% (+70bp); cash flow from operations $1.45B (+23.5%); 43 acquisitions FY25 (~$1.8B annualized revenue); 6 Q4 acquisitions ($29M annualized); Accession Q4 revenue $405M (vs $430-$450M guide; ~200bp Q4 margin impact); long-term adj EBITDAC margin target raised to 32-37%; FY26 Accession synergies $30-$40M; Specialty Distribution contingents -$15M; retail organic +modest improvement; specialty organic improved; effective tax 24-25%; 275 teammates / $23M revenue lost (talent war).
- BRO Q3 2025 / Q2 2025 / Q1 2025 earnings calls — supporting M&A integration + segment dynamics + Accession progress (assumed in line with Q4 trajectory).
- Internal financial_statements view (consolidated annual + cash flow + capital structure).